Vascularized tumor organoids enable immunotherapy testing in tumor-remodeled stroma
Reiner Wimmer, Rok Krese, Louisa Henniger, Steve Niu, Nadege Lagarde, Timon Keller, Inga Clausen, Fabian Köchel, Claudia Ferrara, Inja Waldhauer, Marina Bacac, Nikolche Gjorevski, Fjodor Melnikov, Rémi Villenave
This paper introduces vascularized tumor organoids (VascO) to model tumor microenvironments for immunotherapy testing, showing they can assess drug safety and efficacy in a patient-specific context.
bioRxiv · Jan 26, 2026 · PreprintBioengineering